Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Christ

Showing results (271-280 of 300) with videos related to

Pageof 30
Sort By:
Journal of Internal Medicine|July 3, 2009
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failureM Potocki, T Breidthardt, T Reichlin, et al.
Radiation Oncology (London, England)|April 1, 2026
Bridging radiotherapy before anti-CD19 CAR T-cell therapy for Large B-cell lymphoma - results from a single-center studySebastian M Stolz, Camilla von Wachter, Jonas Willmann, et al.
Clinical and Translational Radiation Oncology|November 24, 2022
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boardsSebastian M Christ, Philip Heesen, Urs J Muehlematter, et al.
Journal of Clinical Microbiology|January 9, 2009
Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assaysIngo Curdt, Gerald Praast, Eva Sickinger, et al.
Zeitschrift Fur Medizinische Physik|June 3, 2025
Safety in MR-enhanced daily adaptive SBRT Radiotherapy using a conventional C-arm linear accelerator: An FMEA approachLotte Wilke, Sebastian M Christ, Riccardo Dal Bello, et al.
Clinical and Translational Radiation Oncology|September 25, 2023
Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRTMaiwand Ahmadsei, Kai Thaler, Elena Gasser, et al.
Journal of Internal Medicine|November 25, 2014
Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemiaN Nigro, B Winzeler, I Suter-Widmer, et al.
Clinical and Translational Radiation Oncology|November 24, 2025
Deep learning [<sup>18</sup>F]-FDG-PET/CT‑based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapyLorenzo Lo Faro, Hubert S Gabryś, Simon Burgermeister, et al.
Clinical and Translational Radiation Oncology|January 30, 2024
Patterns of metastatic spread and tumor burden in unselected cancer patients using PET imaging: Implications for the oligometastatic spectrum theorySebastian M Christ, Kaspar Pohl, Jonas Willmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2022
Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort studyTiuri E Kroese, Sebastian M Christ, Peter S N van Rossum, et al.
Pageof 30

Showing results (271-280 of 300) with videos related to

Sort By:
Pageof 30
Journal of Internal Medicine|July 3, 2009
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failureM Potocki, T Breidthardt, T Reichlin, et al.
Radiation Oncology (London, England)|April 1, 2026
Bridging radiotherapy before anti-CD19 CAR T-cell therapy for Large B-cell lymphoma - results from a single-center studySebastian M Stolz, Camilla von Wachter, Jonas Willmann, et al.
Clinical and Translational Radiation Oncology|November 24, 2022
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boardsSebastian M Christ, Philip Heesen, Urs J Muehlematter, et al.
Journal of Clinical Microbiology|January 9, 2009
Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assaysIngo Curdt, Gerald Praast, Eva Sickinger, et al.
Zeitschrift Fur Medizinische Physik|June 3, 2025
Safety in MR-enhanced daily adaptive SBRT Radiotherapy using a conventional C-arm linear accelerator: An FMEA approachLotte Wilke, Sebastian M Christ, Riccardo Dal Bello, et al.
Clinical and Translational Radiation Oncology|September 25, 2023
Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRTMaiwand Ahmadsei, Kai Thaler, Elena Gasser, et al.
Journal of Internal Medicine|November 25, 2014
Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemiaN Nigro, B Winzeler, I Suter-Widmer, et al.
Clinical and Translational Radiation Oncology|November 24, 2025
Deep learning [<sup>18</sup>F]-FDG-PET/CT‑based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapyLorenzo Lo Faro, Hubert S Gabryś, Simon Burgermeister, et al.
Clinical and Translational Radiation Oncology|January 30, 2024
Patterns of metastatic spread and tumor burden in unselected cancer patients using PET imaging: Implications for the oligometastatic spectrum theorySebastian M Christ, Kaspar Pohl, Jonas Willmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2022
Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort studyTiuri E Kroese, Sebastian M Christ, Peter S N van Rossum, et al.
Pageof 30